| Mouse models of tumor development in neurofibromatosis type 1 K Cichowski, TS Shih, E Schmitt, S Santiago, K Reilly, ME McLaughlin, ... Science 286 (5447), 2172-2176, 1999 | 570 | 1999 |
| Nf1; Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects KM Reilly, DA Loisel, RT Bronson, ME McLaughlin, T Jacks Nature genetics 26 (1), 109-113, 2000 | 488 | 2000 |
| Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1—a … MM Miettinen, CR Antonescu, CDM Fletcher, A Kim, AJ Lazar, ... Human pathology 67, 1-10, 2017 | 334 | 2017 |
| Genetically engineered mouse models in cancer research JC Walrath, JJ Hawes, T Van Dyke, KM Reilly Advances in cancer research 106, 113-164, 2010 | 218 | 2010 |
| A biophysical study of integral membrane protein folding JF Hunt, TN Earnest, O Bousché, K Kalghatgi, K Reilly, C Horváth, ... Biochemistry 36 (49), 15156-15176, 1997 | 215 | 1997 |
| Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression A De Boeck, BY Ahn, C D’Mello, X Lun, SV Menon, MM Alshehri, ... Nature communications 11 (1), 4997, 2020 | 130 | 2020 |
| Malignant peripheral nerve sheath tumors state of the science: leveraging clinical and biological insights into effective therapies AR Kim, DR Stewart, KM Reilly, D Viskochil, MM Miettinen, BC Widemann Sarcoma 2017 (1), 7429697, 2017 | 116 | 2017 |
| Short-range signaling by candidate morphogens of the TGFβ family and evidence for a relay mechanism of induction KM Reilly, DA Melton Cell 86 (5), 743-754, 1996 | 111 | 1996 |
| Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects KM Reilly, RG Tuskan, E Christy, DA Loisel, J Ledger, RT Bronson, ... Proceedings of the National Academy of Sciences 101 (35), 13008-13013, 2004 | 108 | 2004 |
| Comparative pathology of nerve sheath tumors in mouse models and humans AO Stemmer-Rachamimov, DN Louis, GP Nielsen, CR Antonescu, ... Cancer research 64 (10), 3718-3724, 2004 | 98 | 2004 |
| Neurofibromatosis 1 (NF1) heterozygosity results in a cell‐autonomous growth advantage for astrocytes ML Bajenaru, J Donahoe, T Corral, KM Reilly, S Brophy, A Pellicer, ... Glia 33 (4), 314-323, 2001 | 98 | 2001 |
| Neurofibromatosis type 1–associated MPNST state of the science: outlining a research agenda for the future KM Reilly, AR Kim, J Blakely, RE Ferner, DH Gutmann, E Legius, ... JNCI: Journal of the National Cancer Institute 109 (8), djx124, 2017 | 96 | 2017 |
| The neurofibromatosis type 1 tumor suppressor controls cell growth by regulating signal transducer and activator of transcription-3 activity in vitro and in vivo S Banerjee, JN Byrd, SM Gianino, SE Harpstrite, FJ Rodriguez, ... Cancer research 70 (4), 1356-1366, 2010 | 83 | 2010 |
| Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum WA Weiss, M Israel, C Cobbs, E Holland, CD James, DN Louis, C Marks, ... Oncogene 21 (49), 7453-7463, 2002 | 83 | 2002 |
| Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors M Hatano, N Kuwashima, T Tatsumi, JE Dusak, F Nishimura, KM Reilly, ... Journal of translational medicine 2, 1-9, 2004 | 81 | 2004 |
| Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis S Ahlawat, LM Fayad, MS Khan, MA Bredella, GJ Harris, DG Evans, ... Neurology 87 (7_Supplement_1), S31-S39, 2016 | 75 | 2016 |
| The cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patients NM Warrington, T Sun, J Luo, RC McKinstry, PC Parkin, S Ganzhorn, ... Cancer research 75 (1), 16-21, 2015 | 68 | 2015 |
| Isobutylhydroxyamides from the Pericarp of Nepalese Zanthoxylum armatum Inhibit NF1-Defective Tumor Cell Line Growth KP Devkota, J Wilson, CJ Henrich, JB McMahon, KM Reilly, JA Beutler Journal of natural products 76 (1), 59-63, 2013 | 63 | 2013 |
| Brain tumor susceptibility: the role of genetic factors and uses of mouse models to unravel risk KM Reilly Brain pathology 19 (1), 121-131, 2009 | 63 | 2009 |
| Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapies DB Gürsel, YS Connell-Albert, RG Tuskan, T Anastassiadis, JC Walrath, ... Neuro-oncology 13 (6), 610-621, 2011 | 58 | 2011 |
